Detalhe da pesquisa
1.
20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients.
Am J Hematol
; 94(3): 286-290, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516867
2.
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide.
Am J Hematol
; 94(1): 5-9, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30252953
3.
Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger.
Am J Hematol
; 93(12): 1474-1484, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30157297
4.
The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes.
Am J Hematol
; 93(7): E164-E167, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29659079
5.
Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model.
Blood Cancer J
; 9(2): 12, 2019 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30683837
6.
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups.
Mayo Clin Proc
; 94(4): 599-610, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30824279
7.
Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial.
Clin Cancer Res
; 25(16): 4898-4906, 2019 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061068
8.
Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates.
Blood Cancer J
; 8(12): 118, 2018 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455425
9.
Genetic predictors of response to specific drugs in primary myelofibrosis.
Blood Cancer J
; 8(12): 120, 2018 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455475